High-Dose Corticosteroid Use in Severe to Critically Ill Patients With COVID-19: A Nationwide Population-Based Matched Cohort Study.

Raeseok Lee Sung-Yeon Cho Dong-Gun Lee Dukhee Nho

Published in: Journal of Korean medical science (2024)

Among severe to critically ill patients with COVID-19, high-dose corticosteroid use was associated with increased 28-day all-cause mortality and showed a trend toward the development of CAPA.

Keyphrases

high dose
low dose

stem cell transplantation

early onset

drug induced